Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Action inhibitors |
Mechanism CRBN inhibitors(Cereblon inhibitors), MDM2 inhibitors(p53-binding protein Mdm-2 inhibitors), Ubiquitin ligase inhibitors(E3 ubiquitin ligase components inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Immune System Diseases | Discovery | - | 13 Jun 2025 | |
| Inflammation | Discovery | - | 13 Jun 2025 | |
| Neoplasms | Discovery | - | 13 Jun 2025 |





